Evidence map›Paper›PMID 29451852›Full record

ReviewJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Delta Opioids: Neuroprotective Roles in Preclinical Studies.

Shahid Husain

Open access · greenAbstract readReview
In one paragraph

Review in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. [D-AlaFrontiers in surgery · 2022
    Article
  6. Article
  7. Article
  8. Changes in Class I and IIb HDACs by δ-Opioid in Chronic Rat Glaucoma Model.Investigative ophthalmology & visual science · 2020
    Article
  9. Article
  10. Neuroprotective Peptides in Retinal Disease.Journal of clinical medicine · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Shahid HusainHewitt Laboratory of the Ola B. Williams Glaucoma Center, Department of Ophthalmology, Medical University of South Carolina , Charleston, South Carolina.
Medical University of South Carolina · US

Funding

Opioid-Induced RGC Neuroprotection via Changes in Protein AcetylationR01EY027355 · NEI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HUSAIN, SHAHID · 2017 to 2020
$1.5M
NEI NIH HHS R01 EY027355
6 · The paper itself

Abstract

Since ancient times, opioids have been used clinically and abused recreationally. In the early stages (about 1,000 AD) of opium history, an Arab physician, Avicenna, administered opioids to control diarrhea and eye diseases.

Indexed as

Analgesics, OpioidAnimalsGlaucomaHumansOptic Nerve InjuriesReceptors, Opioid, deltaRetinaAnalgesics, OpioidReceptors, Opioid, deltaglaucoma pharmacologyopioid receptorsretinal neuroprotection

Identifiers

PMID29451852
PMCPMC5963634
OpenAlexW2788268164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.